Acquired QT prolongation.
Cahoon
William D
WD
Virginia Commonwealth University Health System, Richmond, VA 23298, USA. wcahoon@mcvh-vcu.edu
D000367:Age Factors; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000009:adverse effects; D001919:Bradycardia / Q000150:complications; D015984:Causality; D016903:Drug Monitoring; D004562:Electrocardiography; D006333:Heart Failure / Q000150:complications; D039563:Histamine H1 Antagonists, Non-Sedating / Q000009:adverse effects; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D008107:Liver Diseases / Q000150:complications; D008133:Long QT Syndrome / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D017202:Myocardial Ischemia / Q000150:complications; D009730:Nursing Assessment; D011619:Psychotropic Drugs / Q000009:adverse effects; D018570:Risk Assessment; D014883:Water-Electrolyte Imbalance / Q000150:complications
D000889:Anti-Arrhythmia Agents; D000890:Anti-Infective Agents; D039563:Histamine H1 Antagonists, Non-Sedating; D011619:Psychotropic Drugs